	Impact of Annotation Level on Multisequence MRI Models for Preoperative Microvascular Invasion Prediction in Hepatocellular Carcinoma. Radiol Imaging Cancer Pan Y, Ye R, Li J, Liu Y, Huang Z, Yue Q, Gao L, Yan C, Li Y. PMID: 41718534 [PubMed - indexed for MEDLINE]
	Pediatric Personalized Deep Learning Models for Segmentation of Hepatoblastoma at CT and MRI. Radiol Imaging Cancer Modanwal G, Kumar S, Viswanathan V, Morin CE, Rees MA, Squires JH, Tang ER, Katzenstein HM, Towbin AJ, Madabhushi A, Schooler GR. PMID: 41718532 [PubMed - indexed for MEDLINE]
	Prospective Registry and Meta-Analysis of Particle Therapy for Hepatocellular Carcinoma: Clinical Outcomes and Real-World Impact. Cancer Med Mizumoto M, Shibuya K, Terashima K, Iwata H, Saito T, Toyama S, Ogino T, Murakami M, Ohno T, Sato Y, Akimoto T, Katoh H, Wakatsuki M, Waki T, Katoh N, Koizumi F, Araya M, Onoe T, Takagi M, Okimoto T, Ogino H, Numajiri H, Shioyama Y, Hashimoto T, Ohba H, Kubo S, Hasegawa K, Maruo K, Aoyama H, Sakurai H. PMID: 41717812 [PubMed - indexed for MEDLINE]
	Mapping fibrosis in colorectal liver metastases (CRLM) with gadobenate dimeglumine-enhanced MRI: prognostic implications and imaging biomarkers. Int J Colorectal Dis Morawska I, Pasicz K, Cieszanowski A. PMID: 41711984 [PubMed - indexed for MEDLINE]
	Neutrophils in the hepatocellular carcinoma microenvironment: orchestrators of progression and immunity. Front Immunol Lian Y, Wang L, Wang J, Zhu D, Lyu W. PMID: 41710884 [PubMed - indexed for MEDLINE]
	Hepatic arterial infusion chemotherapy (HAlC) versus sorafenib for hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer (BCLC) B/C: A systematic review and meta-analysis. PLoS One Chen Z, Fan Y, Luo Y, Ye X, You Z. PMID: 41706717 [PubMed - indexed for MEDLINE]
	Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma. Cancer Med Inoue M, Ogasawara S, Asahara K, Sato R, Watanabe S, Anzai H, Tsubura K, Watabe T, Fujiya M, Akatsuka T, Izai R, Katayama K, Sawada M, Tsuchiya T, Miwa C, Yoshino R, Yonemoto T, Fujimoto K, Unozawa H, Yumita S, Kanzaki H, Koroki K, Kobayashi K, Nakamura M, Kanogawa N, Nakamoto S, Yokoyama M, Kato J, Moriguchi M, Aramaki T, Morimoto N. PMID: 41704221 [PubMed - indexed for MEDLINE]
	Cardiovascular Risk and Prediction Model of Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors in Patients with Liver Cancer. Cardiovasc Toxicol Chen YC, Huang CY, Lien LM, Chen JH, Bintoro BS, Hsieh FI. PMID: 41701417 [PubMed - indexed for MEDLINE]
	Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data. J Med Econ Porta C, Pradelli L, Cirotto G, Majorini MT, Garay OU, Calvaruso V, Fasano T, Napoli L, Foschi FG, Lampertico P. PMID: 41701165 [PubMed - indexed for MEDLINE]
	Dynamic range optimization for treatment time reduction in respiratory-gated proton therapy using RayStation v2025. J Appl Clin Med Phys Cho S, Yu JI, Park HC, Jo K. PMID: 41699829 [PubMed - indexed for MEDLINE]
	Impact of portal vein embolisation uses in colorectal liver metastases: evidence from a rapid review. BMJ Open Moinuddin M, Tran PU, Bekheit M. PMID: 41698722 [PubMed - indexed for MEDLINE]
	Social Determinants of Health Are Associated With Treatment Receipt and Mortality in Patients With Hepatocellular Carcinoma. J Natl Compr Canc Netw Al-Hasan M, Rich NE, Figueroa G, Garces SM, Yekkaluri S, Quirk L, Jarrah M, Yanez M, Solis D, Jones PD, Yopp A, Singal AG. PMID: 41698343 [PubMed - indexed for MEDLINE]
	Comparing of Efficacy and Safety Between Sintilimab Plus IBI305 and PD-1 Inhibitor Plus TKIs in Combination of TACE for uHCC. Liver Int Ya H, Wang K, Qin H, Zhou Y, Lin H, Liu C, Jiang K, Gu J, Li S. PMID: 41696936 [PubMed - indexed for MEDLINE]
	Predictors of one-year adverse outcomes after laparoscopic resection for hepatocellular carcinoma: Development and validation of an early-warning model. World J Gastroenterol Feng W, Ye QW, Wang QL, Chen SY, Ma Y, Meng FL. PMID: 41695284 [PubMed - indexed for MEDLINE]
	Insights into the influencing factors of fecal gut microbiota in hepatocellular carcinoma. World J Gastroenterol Wang YP, Dai JL, Li L, Wen B. PMID: 41695280 [PubMed - indexed for MEDLINE]
	Mechanism of hepatitis C virus-mediated development and progression of liver cirrhosis and hepatocellular carcinoma. World J Gastroenterol Wan KR, Qian C, Liu LM. PMID: 41694486 [PubMed - indexed for MEDLINE]
	Refining early detection of hepatocellular carcinoma: The promise of the GALAD score. World J Gastroenterol Prakash HS, Sehrawat A, Swamy AM, Sundriyal D. PMID: 41694485 [PubMed - indexed for MEDLINE]
	Efficacy and safety of first-line immunotherapy and targeted therapy in advanced HCC: a network meta-analysis with subgroup analysis based on HBV and HCV infection. Front Immunol Li Q, Li H, Ma H, Chen W. PMID: 41694404 [PubMed - indexed for MEDLINE]
	Deep learning techniques for using computed tomography imaging for hepatocellular carcinoma diagnosis, treatment and prognosis. World J Gastroenterol Chen Y, Zhang Q, Zhang MY. PMID: 41693978 [PubMed - indexed for MEDLINE]
	Mac-2 binding protein glycosylation isomer as a novel serum biomarker for recurrence in hepatocellular carcinoma. World J Gastroenterol Stephens KR, Wilson M, Xu M, Gaskins JT, Genova G, Martin Ii RCG. PMID: 41693972 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 75255

Page 1 of 3763



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy